Mari Mizutani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mari Mizutani has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Nakayama
Division of Research and Development for Minimally Invasive Treatment, Cancer Center Keio University School of Medicine Tokyo Japan
4 shared publications - Kaoru Takabayashi
Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan
4 shared publications - Motohiko Kato
Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan
4 shared publications Motoki Sasaki
Center for Diagnostic and Therapeutic Endoscopy Keio University School of Medicine Tokyo Japan
4 shared publicationsYusaku Takatori
Center for Diagnostic and Therapeutic Endoscopy Keio University School of Medicine Tokyo Japan
4 shared publicationsKurato Miyazaki
Division of Research and Development for Minimally Invasive Treatment, Cancer Center Keio University School of Medicine Tokyo Japan
3 shared publications
Latest Publications
- 28 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (8) , e70247
Clinical Outcomes of Underwater Endoscopic Submucosal Dissection for Duodenal Tumors: A Systematic Review and Meta‐Analysis
Background and Study Aim: Underwater endoscopic submucosal dissection (U‐ESD) has recently been introduced as a technique that may improve visualization and submucosal layer expansion. However, the clinical outcomes of U‐ESD for duodenal tumors have not been systematically evaluated. This study aimed to assess the efficacy and safety of U‐ESD for duodenal tumors through a systematic review and meta‐analysis. Patients and Methods: A comprehensive literature search was conducted using PubMed, Scopus, and the Cochrane Library from database inception to December 12, 2025. Studies evaluating U‐ESD for duodenal tumors were included. Primary outcomes included en bloc resection, R0 resection, procedure time, adverse events, and complete mucosal defect closure. Pooled estimates were calculated using a random‐effects model. Results: Four retrospective studies comprising 298 lesions treated with U‐ESD were included. The pooled procedure time was 59 min (95% CI, 48–70 min; I 2 = 72%). The pooled en bloc resection rate was 99% (95% CI, 97%–100%; I 2 = 0%), and the pooled R0 resection rate was 89% (95% CI, 81%–93%; I 2 = 54%). The pooled intraoperative perforation rate was 5% (95% CI, 1%–23%; I 2 = 88%). The pooled delayed perforation and delayed bleeding rates were 1% (95% CI, 0%–3%; I 2 = 0%) and 2% (95% CI, 1%–5%; I 2 = 0%), respectively. Conclusion: Current evidence suggests that U‐ESD is a feasible treatment option for duodenal tumors and is associated with favorable clinical outcomes. However, the available evidence remains limited, and potential biases and concerns regarding generalizability warrant cautious interpretation of these findings.
- 28 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (8) , e70247
Clinical Outcomes of Underwater Endoscopic Submucosal Dissection for Duodenal Tumors: A Systematic Review and Meta‐Analysis
Background and Study Aim: Underwater endoscopic submucosal dissection (U‐ESD) has recently been introduced as a technique that may improve visualization and submucosal layer expansion. However, the clinical outcomes of U‐ESD for duodenal tumors have not been systematically evaluated. This study aimed to assess the efficacy and safety of U‐ESD for duodenal tumors through a systematic review and meta‐analysis. Patients and Methods: A comprehensive literature search was conducted using PubMed, Scopus, and the Cochrane Library from database inception to December 12, 2025. Studies evaluating U‐ESD for duodenal tumors were included. Primary outcomes included en bloc resection, R0 resection, procedure time, adverse events, and complete mucosal defect closure. Pooled estimates were calculated using a random‐effects model. Results: Four retrospective studies comprising 298 lesions treated with U‐ESD were included. The pooled procedure time was 59 min (95% CI, 48–70 min; I 2 = 72%). The pooled en bloc resection rate was 99% (95% CI, 97%–100%; I 2 = 0%), and the pooled R0 resection rate was 89% (95% CI, 81%–93%; I 2 = 54%). The pooled intraoperative perforation rate was 5% (95% CI, 1%–23%; I 2 = 88%). The pooled delayed perforation and delayed bleeding rates were 1% (95% CI, 0%–3%; I 2 = 0%) and 2% (95% CI, 1%–5%; I 2 = 0%), respectively. Conclusion: Current evidence suggests that U‐ESD is a feasible treatment option for duodenal tumors and is associated with favorable clinical outcomes. However, the available evidence remains limited, and potential biases and concerns regarding generalizability warrant cautious interpretation of these findings.
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Adenoma detection rates and complications of colonoscopy in patients aged 75 to 79 vs 70 to 74 years: Propensity score-matching study
Several guidelines recommend discontinuation of routine surveillance colonoscopy after age 75 years. Because Japan has one of the longest life expectancies, we considered ceasing at age 80 years. We compared patients aged 75 to 79 years with those aged 70 to 74 years, regarding adenoma detection rate (ADR), mean number of adenomas per colonoscopy, and adverse events. This propensity score-matching (PSM) study included patients aged 70 to 79 years with a performance status of 0 to 1 who underwent colonoscopies at Toyoshima Endoscopy Clinic between 2017 and 2024. Patients aged 75 to 79 years were matched with those aged 70 to 74 years for baseline characteristics using the propensity score. ADR, mean number of adenomas per colonoscopy, frequency of respiratory depression, hypotension, and delayed post-polypectomy bleeding were compared between the two groups. During the study period, 3415 patients were included. The ADR in patients aged 75 to 79 years was higher than that in patients aged 70 to 74 years (66.5% vs 62.2%, P = 0.021). Mean number of adenomas per colonoscopy in patients aged 75 to 79 years was higher than that in patients aged 70 to 74 years (1.54 vs 1.38, P = 0.014). The two groups did not show significant differences in respiratory depression (2.6% vs 2.3%), hypotension (0.8% vs 1.0%) or delayed post-polypectomy bleeding (0.2% vs 0.4%). Colonoscopies for patients aged 75 to 79 are safe and effective in Japan.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Open AccessAdenoma detection rates and complications of colonoscopy in patients aged 75 to 79 vs 70 to 74 years: Propensity score-matching study
Several guidelines recommend discontinuation of routine surveillance colonoscopy after age 75 years. Because Japan has one of the longest life expectancies, we considered ceasing at age 80 years. We compared patients aged 75 to 79 years with those aged 70 to 74 years, regarding adenoma detection rate (ADR), mean number of adenomas per colonoscopy, and adverse events. This propensity score-matching (PSM) study included patients aged 70 to 79 years with a performance status of 0 to 1 who underwent colonoscopies at Toyoshima Endoscopy Clinic between 2017 and 2024. Patients aged 75 to 79 years were matched with those aged 70 to 74 years for baseline characteristics using the propensity score. ADR, mean number of adenomas per colonoscopy, frequency of respiratory depression, hypotension, and delayed post-polypectomy bleeding were compared between the two groups. During the study period, 3415 patients were included. The ADR in patients aged 75 to 79 years was higher than that in patients aged 70 to 74 years (66.5% vs 62.2%, P = 0.021). Mean number of adenomas per colonoscopy in patients aged 75 to 79 years was higher than that in patients aged 70 to 74 years (1.54 vs 1.38, P = 0.014). The two groups did not show significant differences in respiratory depression (2.6% vs 2.3%), hypotension (0.8% vs 1.0%) or delayed post-polypectomy bleeding (0.2% vs 0.4%). Colonoscopies for patients aged 75 to 79 are safe and effective in Japan.
- 3 November 2024
- Published by Wiley in Digestive Endoscopy
- Vol. 37 (4) , 402-410
Feasibility of endoscopic submucosal dissection including papilla (with video)
Objectives: Endoscopic papillectomy (EP) is a low‐invasive treatment for duodenal tumors including papilla. The limit of lesion size and local recurrence have been issues in EP. We developed endoscopic submucosal dissection (ESD) for the duodenal tumors including papilla (ESDIP: ESD including papilla) to overcome the problems. The aim of this study was to evaluate the feasibility of ESDIP.Methods: We included the patients who underwent ESDIP from August 2010 to January 2024 in this study. We evaluated the retrospective characteristics of patients and lesions, clinical results of ESDIP and of endoscopic retrograde cholangiopancreatography (ERCP) as prevention for delayed adverse events, and pathological findings. We also calculated the cumulative recurrence rate and overall survival rate at 12 months after ESDIP.Results: Fifty‐four patients were included in this study. The mean lesion size was 39 mm. The third‐quarter cases revealed a less than half‐circumferential lesion, and the one case with a full‐circumferential lesion. Resection was accomplished in 96% (n = 52), and also the en‐bloc resection rate was 96%. Of the cases in accomplished resection, 98% of patients were intubated with a pancreaticobiliary drainage tube by ERCP. Intraprocedural perforation occurred in eight cases. Delayed bleeding occurred in 10 cases. Delayed perforation was seen only in one case. The incidence of post‐ERCP pancreatitis was 25%. Cumulative local recurrence rate and the overall survival rate were 15% and 96%, respectively.Conclusion: ESDIP may be feasible for duodenal tumors including papilla, and is a potential alternative option to avoid pancreaticoduodenectomy.
- 3 November 2024
- Published by Wiley in Digestive Endoscopy
- Vol. 37 (4) , 402-410
Feasibility of endoscopic submucosal dissection including papilla (with video)
Objectives: Endoscopic papillectomy (EP) is a low‐invasive treatment for duodenal tumors including papilla. The limit of lesion size and local recurrence have been issues in EP. We developed endoscopic submucosal dissection (ESD) for the duodenal tumors including papilla (ESDIP: ESD including papilla) to overcome the problems. The aim of this study was to evaluate the feasibility of ESDIP.Methods: We included the patients who underwent ESDIP from August 2010 to January 2024 in this study. We evaluated the retrospective characteristics of patients and lesions, clinical results of ESDIP and of endoscopic retrograde cholangiopancreatography (ERCP) as prevention for delayed adverse events, and pathological findings. We also calculated the cumulative recurrence rate and overall survival rate at 12 months after ESDIP.Results: Fifty‐four patients were included in this study. The mean lesion size was 39 mm. The third‐quarter cases revealed a less than half‐circumferential lesion, and the one case with a full‐circumferential lesion. Resection was accomplished in 96% (n = 52), and also the en‐bloc resection rate was 96%. Of the cases in accomplished resection, 98% of patients were intubated with a pancreaticobiliary drainage tube by ERCP. Intraprocedural perforation occurred in eight cases. Delayed bleeding occurred in 10 cases. Delayed perforation was seen only in one case. The incidence of post‐ERCP pancreatitis was 25%. Cumulative local recurrence rate and the overall survival rate were 15% and 96%, respectively.Conclusion: ESDIP may be feasible for duodenal tumors including papilla, and is a potential alternative option to avoid pancreaticoduodenectomy.
- 21 January 2024
- Published by Wiley in Digestive Endoscopy
- Vol. 36 (8) , 918-926
Prospective cross‐organ analysis for the causes of fever and increased inflammatory response after endoscopic resection
Objectives: Fever and increased inflammatory responses sometimes occur following endoscopic resection (ER). However, the differences in causes according to the organ are scarcely understood, and several modified ER techniques have been proposed. Therefore, we conducted a comprehensive prospective study to investigate the cause of fever and increased inflammatory response across multiple organs after ER.Methods: We included patients who underwent gastrointestinal endoscopic submucosal dissection (ESD) and duodenal endoscopic mucosal resection at our hospital between January 2020 and April 2022. Primary endpoints were fever and increased C‐reactive protein (CRP) levels following ER. The secondary endpoints were risk factors for aspiration pneumonia. Blood tests and radiography were performed on the day after ER, and computed tomography was performed if the cause was unknown.Results: Among the 822 patients included, aspiration pneumonia was the most common cause of fever and increased CRP levels after ER of the upper gastrointestinal tract (esophagus, 53%; stomach, 48%; and duodenum, 71%). Post‐ER coagulation syndrome was most common after colorectal ESD (38%). On multivariate logistic regression analysis, lesions located in the esophagus (odds ratio [OR] 3.57; P < 0.001) and an amount of irrigation liquid of ≥1 L (OR 3.71; P = 0.003) were independent risk factors for aspiration pneumonia.Conclusions: Aspiration pneumonia was the most common cause of fever after upper gastrointestinal ER and post‐ER coagulation syndrome following colorectal ESD. Lesions in the esophagus and an amount of irrigation liquid of ≥1 L were independent risk factors for aspiration pneumonia.
- 21 January 2024
- Published by Wiley in Digestive Endoscopy
- Vol. 36 (8) , 918-926
Prospective cross‐organ analysis for the causes of fever and increased inflammatory response after endoscopic resection
Objectives: Fever and increased inflammatory responses sometimes occur following endoscopic resection (ER). However, the differences in causes according to the organ are scarcely understood, and several modified ER techniques have been proposed. Therefore, we conducted a comprehensive prospective study to investigate the cause of fever and increased inflammatory response across multiple organs after ER.Methods: We included patients who underwent gastrointestinal endoscopic submucosal dissection (ESD) and duodenal endoscopic mucosal resection at our hospital between January 2020 and April 2022. Primary endpoints were fever and increased C‐reactive protein (CRP) levels following ER. The secondary endpoints were risk factors for aspiration pneumonia. Blood tests and radiography were performed on the day after ER, and computed tomography was performed if the cause was unknown.Results: Among the 822 patients included, aspiration pneumonia was the most common cause of fever and increased CRP levels after ER of the upper gastrointestinal tract (esophagus, 53%; stomach, 48%; and duodenum, 71%). Post‐ER coagulation syndrome was most common after colorectal ESD (38%). On multivariate logistic regression analysis, lesions located in the esophagus (odds ratio [OR] 3.57; P < 0.001) and an amount of irrigation liquid of ≥1 L (OR 3.71; P = 0.003) were independent risk factors for aspiration pneumonia.Conclusions: Aspiration pneumonia was the most common cause of fever after upper gastrointestinal ER and post‐ER coagulation syndrome following colorectal ESD. Lesions in the esophagus and an amount of irrigation liquid of ≥1 L were independent risk factors for aspiration pneumonia.
- 26 January 2023
- Published by Wiley in Digestive Endoscopy
- Vol. 35 (3) , 394-399
Novel closure method for a large mucosal defect after endoscopic resection: String clip suturing method with an anchor
Duodenal endoscopic submucosal dissection (ESD) is a high‐risk technique; however, prophylactic closure of mucosal defects reduces the risk. Unfortunately, we have encountered cases where closure is difficult, especially in large lesions. Therefore, we developed a novel closure technique, a string clip suturing method with an anchor (SCSM‐A). This study aimed to elucidate the feasibility of this method. Five patients underwent this method for the closure of mucosal defects after duodenal ESD. The initial string clip was deployed at the anal end of the mucosal defects and the second clip was deployed at the other end of the mucosal defect. A third clip was deployed on the muscular layer in the middle of the mucosal defect. The free end of the string was pulled, and additional clips were deployed around the first to the third clips for complete closure. Because of grasping the muscle layer, SCSM‐A can be employed for secure closure without creating a pocket. We reviewed the background and clinical course of hospitalization of patients who underwent this method. The resected specimens ranged from 52 to 103 mm in diameter. Complete closure of the mucosal defects was possible in all the cases. There were no adverse events, and no cases required additional treatment. All the patients were discharged within 7 days. The new method achieved secure closure even for large mucosal defects after duodenal ESD. This is a technique that can be applied to other organs, e.g., the colon.
- 26 January 2023
- Published by Wiley in Digestive Endoscopy
- Vol. 35 (3) , 394-399
Novel closure method for a large mucosal defect after endoscopic resection: String clip suturing method with an anchor
Duodenal endoscopic submucosal dissection (ESD) is a high‐risk technique; however, prophylactic closure of mucosal defects reduces the risk. Unfortunately, we have encountered cases where closure is difficult, especially in large lesions. Therefore, we developed a novel closure technique, a string clip suturing method with an anchor (SCSM‐A). This study aimed to elucidate the feasibility of this method. Five patients underwent this method for the closure of mucosal defects after duodenal ESD. The initial string clip was deployed at the anal end of the mucosal defects and the second clip was deployed at the other end of the mucosal defect. A third clip was deployed on the muscular layer in the middle of the mucosal defect. The free end of the string was pulled, and additional clips were deployed around the first to the third clips for complete closure. Because of grasping the muscle layer, SCSM‐A can be employed for secure closure without creating a pocket. We reviewed the background and clinical course of hospitalization of patients who underwent this method. The resected specimens ranged from 52 to 103 mm in diameter. Complete closure of the mucosal defects was possible in all the cases. There were no adverse events, and no cases required additional treatment. All the patients were discharged within 7 days. The new method achieved secure closure even for large mucosal defects after duodenal ESD. This is a technique that can be applied to other organs, e.g., the colon.
- 16 July 2010
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 42 (S 02) , E183-E184
Narrowband imaging colonoscopy with a transparent hood for diagnosis of a squamous cell carcinoma in situ in the anal canal
Anal cancer is a relatively rare malignancy [ 1 ]. An analysis of the National Cancer Data Base showed that most patients with anal carcinoma (71.1 %) required invasive treatments such as chemoradiation therapy with or without surgery, and the 5-year overall survival for these patients was 58.0 % [ 2 ]. Anal squamous cell carcinoma in situ (CIS) accounts for almost 10 % of all anal carcinomas [ 3 ]. Here we present a case of anal canal squamous cell CIS incidentally detected in a patient at low risk of developing anal cancer. The presence, histology, and spread and depth invasion of the tumor were correctly diagnosed by narrowband imaging (NBI) with magnification. An asymptomatic 62-year-old woman underwent conventional colonoscopy, which revealed an ill-defined, flat lesion with scattered reddish spots at the dentate line ([ Fig. 1 ]). Fig. 1 Colonoscopy with a transparent hood showing an ill-defined, flat lesion, slightly reddish at the dentate line. NBI without magnification showed a well-demarcated brownish area, 25 mm in size, as well as scattered brown dots at the same site ([ Fig. 2 a ]). Fig. 2 a Narrowband imaging (NBI) without magnification showing a well-demarcated, brownish area, 25 mm in size, and scattered brown dots at the same site. b, c NBI with magnification showing dilated and tortuous capillaries mimicking intraepithelial papillary capillary loops in the esophagus. NBI with magnification disclosed dilated and tortuous capillaries, mimicking intraepithelial papillary capillary loops in the esophagus ([ Fig. 2 b, c ]). Lugol chromoendoscopy revealed a well-demarcated, unstained area corresponding to the brownish area seen with NBI ([ Fig. 3 ]). Fig. 3 Lugol chromoendoscopy showing a well-demarcated, unstained area corresponding to the brownish area shown by narrowband imaging. A biopsy specimen was taken for histological evaluation, which suggested squamous cell carcinoma, and transanal resection was carried out. On histological examination, the resected specimen showed squamous cell CIS with high grade intraepithelial neoplasia ([ Fig. 4 ]); the surgical margin was free of tumor. Fig. 4 The resected specimen was a squamous cell carcinoma in situ with high grade intraepithelial neoplasia. To the best of our knowledge, this is the first report of an anal CIS detected by NBI. NBI with magnifying endoscopy showed an abnormal vascular pattern of intraepithelial papillary capillary looping, which suggested that the lesion was a squamous cell cancer [ 4 ]. The spread of this tumor was also clearly demarcated with NBI. In the present case, we used a magnifying colonoscope with a transparent hood [ 5 ]. A transparent hood also ensures good vizualization of the anal canal without retroflexion of the colonoscope. Therefore, NBI colonoscopy with a transparent hood is useful for screening for anal squamous cell carcinoma. Competing interests: None Endoscopy_UCTN_Code_CCL_1AD_2AB
- 16 July 2010
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 42 (S 02) , E183-E184
Narrowband imaging colonoscopy with a transparent hood for diagnosis of a squamous cell carcinoma in situ in the anal canal
Anal cancer is a relatively rare malignancy [ 1 ]. An analysis of the National Cancer Data Base showed that most patients with anal carcinoma (71.1 %) required invasive treatments such as chemoradiation therapy with or without surgery, and the 5-year overall survival for these patients was 58.0 % [ 2 ]. Anal squamous cell carcinoma in situ (CIS) accounts for almost 10 % of all anal carcinomas [ 3 ]. Here we present a case of anal canal squamous cell CIS incidentally detected in a patient at low risk of developing anal cancer. The presence, histology, and spread and depth invasion of the tumor were correctly diagnosed by narrowband imaging (NBI) with magnification. An asymptomatic 62-year-old woman underwent conventional colonoscopy, which revealed an ill-defined, flat lesion with scattered reddish spots at the dentate line ([ Fig. 1 ]). Fig. 1 Colonoscopy with a transparent hood showing an ill-defined, flat lesion, slightly reddish at the dentate line. NBI without magnification showed a well-demarcated brownish area, 25 mm in size, as well as scattered brown dots at the same site ([ Fig. 2 a ]). Fig. 2 a Narrowband imaging (NBI) without magnification showing a well-demarcated, brownish area, 25 mm in size, and scattered brown dots at the same site. b, c NBI with magnification showing dilated and tortuous capillaries mimicking intraepithelial papillary capillary loops in the esophagus. NBI with magnification disclosed dilated and tortuous capillaries, mimicking intraepithelial papillary capillary loops in the esophagus ([ Fig. 2 b, c ]). Lugol chromoendoscopy revealed a well-demarcated, unstained area corresponding to the brownish area seen with NBI ([ Fig. 3 ]). Fig. 3 Lugol chromoendoscopy showing a well-demarcated, unstained area corresponding to the brownish area shown by narrowband imaging. A biopsy specimen was taken for histological evaluation, which suggested squamous cell carcinoma, and transanal resection was carried out. On histological examination, the resected specimen showed squamous cell CIS with high grade intraepithelial neoplasia ([ Fig. 4 ]); the surgical margin was free of tumor. Fig. 4 The resected specimen was a squamous cell carcinoma in situ with high grade intraepithelial neoplasia. To the best of our knowledge, this is the first report of an anal CIS detected by NBI. NBI with magnifying endoscopy showed an abnormal vascular pattern of intraepithelial papillary capillary looping, which suggested that the lesion was a squamous cell cancer [ 4 ]. The spread of this tumor was also clearly demarcated with NBI. In the present case, we used a magnifying colonoscope with a transparent hood [ 5 ]. A transparent hood also ensures good vizualization of the anal canal without retroflexion of the colonoscope. Therefore, NBI colonoscopy with a transparent hood is useful for screening for anal squamous cell carcinoma. Competing interests: None Endoscopy_UCTN_Code_CCL_1AD_2AB